1-12 of 12
Andrzej Mital
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term results of patients receiving zanubrutinib in the phase 3 ALPINE study confirm sustained benefit of zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (R/R CLL/SLL): Up to 6 years of follow-up with the long-term extension (LTE1)

Free
Constantine Tam, Andrzej Mital, Robert Weinkove, Wojciech Jurczak, Xin Yan, Nataliya Kuptsova-Clarkson, Tian Tian, Megan Wang, Jamie Hirata
Journal: Blood
Blood (2025) 146 (Supplement 1): 2123.
https://doi.org/10.1182/blood-2025-2123
Published: 2025
Journal Articles

Efficacy and safety results from the primary analysis of the pivotal summit trial: Bezuclastinib in adults with non-advanced systemic mastocytosis

Free
Lindsay Rein, Nathan Boggs, Prithviraj Bose, Brian Modena, Vito Sabato, Karin Hartmann, Cem Akin, Tracy George, Cecilia Arana Yi, Hanneke Oude Elberink, Deepti Radia, Andreas Reiter, Miguel Piris-Villaespesa, Ingunn Dybedal, Jens Panse, Stephen Oh, Pankit Vachhani, Anthony Hunter, Mariana Castells, Cristina Bulai Livideanu, Paul van Daele, Arnold Kirshenbaum, Ivan Alvarez-Twose, Jennifer Vaughn, Minakshi Taparia, Sonia Cerquozzi, Andrzej Mital, Marek Hus, ALESSANDRA ROMANO, John Fahrenholz, Frederick Lansigan, Cristina Papayannidis, Helena Pomares, Michela Rondoni, Celalettin Ustun, Richard Herrscher, Michael Manning, Stéphane Barete, Mar Guilarte, Candido Rivera, Jonathan Bernstein, Peter Vadas, Chiara Elena, Derek McCulloch, Nina Orfali, Clodagh Keohane, Francesco Mannelli, Philippe Schafhausen, Amanda Pilla, Jenna Zhang, Lei Sun, Nisha Shah, Hina Jolin, Rachael Easton, Jessica Sachs, Frank Siebenhaar, Daniel Deangelo
Journal: Blood
Blood (2025) 146 (Supplement 1): 80.
https://doi.org/10.1182/blood-2025-80
Published: 2025
Journal Articles

Minimal residual disease-guided venetoclax plus rituximab for patients with previously untreated chronic lymphocytic leukemia (VERITA PALG-CLL5): primary endpoint analysis of the prospective, multicenter, Phase 2 trial

Free
Krzysztof Jamroziak, Elzbieta Iskierka-Jazdzewska, Tadeusz Robak, Klaudia Zielonka, Sebastian Giebel, Kamil Wisniewski, Joanna Drozd-Sokolowska, Justyna Rybka, Weronika Piszczek, Monika Joks, Anna Dabrowska-Iwanicka, Andrzej Mital, Pawel Steckiewicz, Ewa Lech-Marańda, Marcin Jasinski, Marcin Rymko, Dawid Marciniak, Tomasz Wrobel, Lidia Gil, Joanna Romejko-Jarosinska, Dorota Kruk-Kwapisz, Agnieszka Chudy, Marcin Machnicki, Krzysztof Giannopoulos, Tomasz Stoklosa, Tomasz Górecki, Bartosz Pula
Journal: Blood
Blood (2025) 146 (Supplement 1): 5675.
https://doi.org/10.1182/blood-2025-5675
Published: 2025
Journal Articles

Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE

Free
Clinical Trials & Observations
Jennifer R. Brown, Barbara Eichhorst, Nicole Lamanna, Susan M. O’Brien, Constantine S. Tam, Lugui Qiu, Wojciech Jurczak, Keshu Zhou, Martin Šimkovič, Jiří Mayer, Amanda Gillespie-Twardy, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Osterborg, Habte A. Yimer, Megan Wang, Tommi Salmi, Liping Wang, Jessica Li, Kenneth Wu, Aileen Cohen, Mazyar Shadman
Journal: Blood
Blood (2024) 144 (26): 2706–2717.
https://doi.org/10.1182/blood.2024024667
Published: 2024
Includes: Supplemental data
Journal Articles

MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: First Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)

Free
Krzysztof Jamroziak, Elzbieta Iskierka-Jazdzewska, Sebastian Giebel, Kamil Wisniewski, Joanna Drozd-Sokolowska, Tadeusz Robak, Justyna Rybka, Weronika Piszczek, Monika Joks, Anna Paulina Dabrowska-Iwanicka, Andrzej Mital, Paweł Steckiewicz, Ewa Lech-Maranda, Marcin Jasinski, Marcin Rymko, Dawid Marciniak, Tomasz Wrobel, Lidia Gil, Joanna Romejko-Jarosinska, Dorota Kruk-Kwapisz, Agnieszka Chudy, Krzysztof Giannopoulos, Tomasz Stoklosa, Bartosz Michal Pula
Journal: Blood
Blood (2024) 144 (Supplement 1): 3242.
https://doi.org/10.1182/blood-2024-201076
Published: 2024
Journal Articles

Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-Free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL)

Free
Jennifer R. Brown, Barbara F. Eichhorst, Nicole Lamanna, Susan M. O'Brien, Constantine S. Tam, Luqui Qiu, Maciej Kaźmierczak, Wojciech Jurczak, Keshu Zhou, Martin Simkovic, Jiri Mayer, Amanda L. Gillespie-Twardy, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Osterborg, Habte A. Yimer, Megan (Der Yu) Wang, Tommi Salmi, Liping Wang, Jessica Li, Kenneth Wu, Aileen Cleary Cohen, Mazyar Shadman
Journal: Blood
Blood (2023) 142 (Supplement 1): 202.
https://doi.org/10.1182/blood-2023-174289
Published: 2023
Journal Articles

Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared with Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL): Results from Final Analysis of ALPINE Randomized Phase 3 Study

Free
Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen, Nicole Lamanna, Susan M. O'Brien, Constantine S. Tam, Lugui Qiu, Maciej Kaźmierczak, Wojciech Jurczak, Keshu Zhou, Martin Šimkovič, Jiri Mayer, Amanda L. Gillespie-Twardy, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Österborg, Habte A. Yimer, Tommi Salmi, Megan (Der Yu) Wang, Lina Fu, Jessica Li, Kenneth Wu, Aileen Cohen, Mazyar Shadman
Journal: Blood
Blood (2022) 140 (Supplement 2): LBA-6.
https://doi.org/10.1182/blood-2022-171538
Published: 2022
Journal Articles

Polish Myelodysplastic Syndromes Registry- Report of 15 Months of Activity.

Free
Jadwiga Dwilewicz-Trojaczek, Krzysztof Madry, Beata Stella-Holowiecka, Andrzej Mital, Anna Szmigielska, Agata Obara, Anita Sikorska, Ewa Nita, Wlodzimierz Mendrek, Elzbieta Wiater, Magdalena Zalewska, Monika Biedron, Anna Jachalska, Ewa Wasilewska, Malgorzata Wojciechowska, Agnieszka Kopacz, Adam Nowicki, Agnieszka Kolkowska, Renata Guzicka-Kazimierczak, Maria Pedziwiatr, Mariola Sedzimirska, Ewa Nowak, Anna Blasiak, Ewa Baranska, Maria Soroka-Wojtaszko, Slawomir Gornik, Witold Kruger, Katarzyna Katinas, Zoriana Salamanczuk, Bozena Sokolowska, Wieslaw W. Jedrzejczak, MD, PhD, Andrzej Deptala
Journal: Blood
Blood (2009) 114 (22): 4848.
https://doi.org/10.1182/blood.V114.22.4848.4848
Published: 2009
Journal Articles

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

Free
Jerzy Z Blonski, Tadeusz Robak, Jacek Trelinski, Krzysztof Chojnowski, Krzysztof Warzocha, Ilona Seferynska, Lech Konopka, Bernadetta Ceglarek, Malgorzata Calbecka, Aleksandra Kostyra, Beata Stella-Holowiecka, Janusz Kloczko, Anna Dmoszynska, Malgorzata Kowal, Krzysztof Lewandowski, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Kazimierz Kuliczkowski, Stanislaw Potoczek, Andrzej Hellmann, MD, PhD, Andrzej Mital, Aleksander B. Skotnicki, Wieslaw Nowak, Kazimierz Sulek, Andrzej Zdunczyk, Krystyna Zawilska
Journal: Blood
Blood (2008) 112 (11): 4179.
https://doi.org/10.1182/blood.V112.11.4179.4179
Published: 2008
Journal Articles

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Free
Tadeusz Robak, MD, PhD, Jerzy Z Blonski, Krzysztof Jamroziak, Joanna Gora-Tybor, Beata Stella-Holowiecka, Lech Konopka, Bernadeta Ceglarek, Krzysztof Warzocha, Ilona Seferynska, Janusz Kloczko, Jaroslaw Piszcz, Malgorzata Calbecka, Aleksandra Kostyra, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Anna Dmoszynska, Malgorzata Kowal, Krystyna Zawilska, Alina Grzywacz, Andrzej Hellmann, MD, PhD, Andrzej Mital, Andrzej Zdunczyk, Jacek Dybowicz, Kazimierz Kuliczkowski, Stanislaw Potoczek, Aleksander Skotnicki, Maria Nowakowska-Domagala, Krzysztof Lewandowski, Kazimierz Sulek
Journal: Blood
Blood (2008) 112 (11): 2103.
https://doi.org/10.1182/blood.V112.11.2103.2103
Published: 2008
Journal Articles

Influence of Chromosomal Aberrations on Response to First Line Therapy in B-Cell Chronic Lymphocytic Leukemia: Interim Analysis of PALG-CLL3 Randomized Study Comparing Cladribine Plus Cyclophosphamide vs Fludarabine Plus Cyclophosphamide.

Free
Tadeusz Robak, Jerzy Z. Blonski, Ewa Wawrzyniak, Aleksandra Palacz, Joanna Gora-Tybor, Krzysztof Jamroziak, Jaroslaw Piszcz, Janusz S. Kloczko, Dorota Koczkodaj, Malgorzata Kowal, Anna Dmoszynska, Andrzej Mital, Andrzej Hellmann
Journal: Blood
Blood (2007) 110 (11): 2046.
https://doi.org/10.1182/blood.V110.11.2046.2046
Published: 2007
Journal Articles

Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.

Free
Tadeusz Robak, Jerzy Z. Blonski, Joanna Gora-Tybor, Jacek Najda, Beata Stella-Holowiecka, Malgorzata Calbecka, Malgorzata Kowal, Anna Dmoszynska, Bernadeta Ceglarek, Lech Konopka, Tomasz Szpila, Krzysztof Warzocha, Jaroslaw Piszcz, Janusz Kloczko, Krystyna Zawilska, Andrzej Mital, Andrzej Hellmann, Stanislaw Potoczek, Kazimierz Kuliczkowski, Kazimierz Sulek, Andrzej Zdunczyk, Marek Kasznicki
Journal: Blood
Blood (2005) 106 (11): 2121.
https://doi.org/10.1182/blood.V106.11.2121.2121
Published: 2005